Reliability of LoSCAT Score for Activity and Tissue Damage Assessment in a Large Cohort of Patients with Juvenile Localized Scleroderma

Overview

Journal Pediatr Rheumatol Online J

Publisher Biomed Central

Specialty Pediatrics

Date 2018 Jun 20

PMID 29914516

Citations 7

Authors

Anna Agazzi

Gloria Fadanelli

Fabio Vittadello

Francesco Zulian

Giorgia Martini

Affiliations

Soon will be listed here.

Abstract

Objectives: To assess reliability of the two indexes of Localized Scleroderma Cutaneous Assessment Tool (LoSCAT), the modified Localized Scleroderma Skin Severity Index (mLoSSI) and the Localized Scleroderma Skin Damage Index (LoSDI), when applied by clinicians with different experience in scoring and managing patients with JLS. Secondary aim was to compare LoSCAT and infrared thermography (IRT) in monitoring lesions over time.

Methods: Consecutive children with Juvenile Localized Scleroderma (JLS) were blindly evaluated by three examiners with different experience in Paediatric Rheumatology and with no experience in LoSCAT use. At each visit, patients were assessed by LoSCAT and IRT. Sensitivity to change of LoSCAT and IRT was assessed in a group of patients 3-6 months later. Inter-rater reliability was assessed by Intraclass Correlation Coefficient (ICC) and variance analysis (ANOVA).

Findings: Forty-seven patients (129 lesions) entered the study, and 26 (79 lesions) were re-evaluated with same modality after 4.5 (SD 1.5) months. mLoSSI showed excellent inter-rater reliability expressed by ICC 0.965 confirmed by ANOVA. Similarly, inter-rater reliability for LoSDI was good (ICC = 0.774) but worse concordance among examiners was observed. A comparable improvement of mLoSSI in all anatomic sites was noted by all examiners in 79 lesions examined in two subsequent visits and was consistent with thermography.

Conclusions: Different clinical experience in JLS did not influence clinical judgement in mLoSSI which showed excellent concordance, whereas LoSDI is less precise in damage assessment and not completely reliable in monitoring skin changes. Infrared thermography confirms to be a helpful tool for detecting disease activity and reliable in monitoring lesions over time.

Citing Articles

Comparison of 3D facial photographs and clinical documentation in patients with craniofacial morphea.

Nguyen T, Cohen S, Shaw K, Dedeoglu F, Vleugels R, Ganske I Skin Health Dis. 2024; 4(6):e438.

PMID: 39624764 PMC: 11608905. DOI: 10.1002/ski2.438.

National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients.

Branton S, Stubbs L, Havrilla H, Torok K J Scleroderma Relat Disord. 2024; :23971983241272460.

PMID: 39544906 PMC: 11559527. DOI: 10.1177/23971983241272460.

Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised Scleroderma.

Desai Y, Jaki T, Beresford M, Burnett T, Eleftheriou D, Jacobe H AMRC Open Res. 2024; 3:20.

PMID: 38708070 PMC: 11064983. DOI: 10.12688/amrcopenres.13008.1.

Superb microvascular imaging for evaluating the activity of juvenile localised scleroderma: a preliminary study.

Chen X, Zhou L, Xia Y, Wong Y, He Q, Tang P Eur Radiol. 2024; 34(10):6376-6383.

PMID: 38652159 PMC: 11399200. DOI: 10.1007/s00330-024-10738-z.

Recent Advances in Treatment of Systemic Sclerosis and Morphea.

Teske N, Fett N Am J Clin Dermatol. 2023; 25(2):213-226.

PMID: 38087156 DOI: 10.1007/s40257-023-00831-2.

References

Kelsey C, Torok K . The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population. J Am Acad Dermatol. 2013; 69(2):214-20. PMC: 3720681. DOI: 10.1016/j.jaad.2013.02.007. View

Zulian F, Athreya B, Laxer R, Nelson A, Oliveira S, Punaro M . Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford). 2005; 45(5):614-20. DOI: 10.1093/rheumatology/kei251. View

Schanz S, Henes J, Ulmer A, Kotter I, Fierlbeck G, Claussen C . Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach. AJR Am J Roentgenol. 2013; 200(4):W376-82. DOI: 10.2214/AJR.12.9335. View

Zulian F . Systemic sclerosis and localized scleroderma in childhood. Rheum Dis Clin North Am. 2008; 34(1):239-55. DOI: 10.1016/j.rdc.2007.11.004. View

Di Giovanni C, Puggina S, Meneghel A, Vittadello F, Martini G, Zulian F . Cone beam computed tomography for the assessment of linear scleroderma of the face. Pediatr Rheumatol Online J. 2018; 16(1):1. PMC: 5751836. DOI: 10.1186/s12969-017-0218-5. View

Garcia-Romero M, Laxer R, Pope E . Correlation of clinical tools to determine activity of localized scleroderma in paediatric patients. Br J Dermatol. 2015; 174(2):408-10. DOI: 10.1111/bjd.14001. View

Weibel L, Howell K, Visentin M, Rudiger A, Denton C, Zulian F . Laser Doppler flowmetry for assessing localized scleroderma in children. Arthritis Rheum. 2007; 56(10):3489-95. DOI: 10.1002/art.22920. View

Wortsman X, Wortsman J, Sazunic I, Carreno L . Activity assessment in morphea using color Doppler ultrasound. J Am Acad Dermatol. 2011; 65(5):942-8. DOI: 10.1016/j.jaad.2010.08.027. View

Arkachaisri T, Vilaiyuk S, Li S, ONeil K, Pope E, Higgins G . The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol. 2009; 36(12):2819-29. PMC: 3690503. DOI: 10.3899/jrheum.081284. View

10.

Arkachaisri T, Vilaiyuk S, Torok K, Medsger Jr T . Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford). 2009; 49(2):373-81. PMC: 3498950. DOI: 10.1093/rheumatology/kep361. View

11.

Martini G, Murray K, Howell K, Harper J, Atherton D, Woo P . Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford). 2002; 41(10):1178-82. DOI: 10.1093/rheumatology/41.10.1178. View

12.

Li S, Liebling M, Haines K, Weiss J, Prann A . Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2011; 63(5):735-42. DOI: 10.1002/acr.20407. View

13.

Horger M, Fierlbeck G, Kuemmerle-Deschner J, Tzaribachev N, Wehrmann M, Claussen C . MRI findings in deep and generalized morphea (localized scleroderma). AJR Am J Roentgenol. 2007; 190(1):32-9. DOI: 10.2214/AJR.07.2163. View

14.

Nezafati K, Cayce R, Susa J, Setiawan A, Tirkes T, Bendeck S . 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma). Arch Dermatol. 2011; 147(9):1112-5. DOI: 10.1001/archdermatol.2011.243. View

15.

Laxer R, Zulian F . Localized scleroderma. Curr Opin Rheumatol. 2006; 18(6):606-13. DOI: 10.1097/01.bor.0000245727.40630.c3. View

16.

Zulian F, Meneghesso D, Grisan E, Vittadello F, Belloni Fortina A, Pigozzi B . A new computerized method for the assessment of skin lesions in localized scleroderma. Rheumatology (Oxford). 2007; 46(5):856-60. DOI: 10.1093/rheumatology/kel446. View